Search
LI-301
go.drugbank.com/drugs/DB05509ExperimentalLI 301 is an orally bio-available compound delivered in a fast melt mechanism with taste masking enabling it to be taken anytime without water. … This results in a slight dulling of sensation that can be used to treat premature ejaculation without interfering with normal sexual pleasure or orgasm.
Sodium sulfide
go.drugbank.com/drugs/DB11159ApprovedH2S is an endogenous gaseous transmitter that exhibits anti-inflammatory and antiapoptotic properties. … Along with its hydrate form, sodium sulfide releases hydrogen sulfide (H2S) when in contact with moist air.
Dialyzable leukocyte extract
go.drugbank.com/drugs/DB16530InvestigationalIt is thought to have widespread effects on the immune system, and effective in treating infections and immunological issues. … Transferon is comprised of several peptides mixed from human dialyzable leucocyte extracts and acts as an immunomodulator.
Drinabant
go.drugbank.com/drugs/DB05750InvestigationalAVE-1625 is an oral selective and potent antagonist of cannabinoid 1 (CB1) receptors having the same mechanism of action as rimonabant. … It is currently developed in obesity and its associated comorbidities. AVE-1625 is also being developed for the treatment of Alzheimer disease.
Cymarin
go.drugbank.com/drugs/DB13240ExperimentalCategories: Compounds used in a research, industrial, or household settingCypermethrin
go.drugbank.com/drugs/DB13721InvestigationalCategories: Compounds used in a research, industrial, or household settingCyfluthrin
go.drugbank.com/drugs/DB13828ExperimentalCategories: Compounds used in a research, industrial, or household settingStevioside
go.drugbank.com/drugs/DB16882InvestigationalCategories: Compounds used in a research, industrial, or household settingSatraplatin
go.drugbank.com/drugs/DB04996InvestigationalAs an investigation drug, it has not yet received U.S. Food and Drug Administration (FDA) approval and is not available in retail pharmacies.